Colin advises clients throughout their lifecycle (all the way from start-up/spin-out to multinational listed companies) on the commercialisation of their intellectual property rights. In particular, advising on licensing deals, collaborations and R&D projects, distribution and manufacturing and the IP, commercial and regulatory aspects of M&A, VC investments and IPOs.
Having a 1st class degree in Cell Biology his practice has naturally become focused on the life sciences, healthcare and technology (with a particular focus on med-tech and clean-tech) sectors.
|Since 2020||Partner, Taylor Wessing|
|2016 - 2020||Senior Counsel, Taylor Wessing|
|2010 - 2016||Senior Associate, Taylor Wessing|
|2006 - 2010||Associate,Taylor Wessing|
|2004 - 2006||Associate, Linklaters|
|2002 - 2004||Trainee, Linklaters|
|2013||MSc Energy Environmental Technology and Economics, London City University|
|2005||Diploma in Intellectual Property Law and Practice, Bristol University|
|2004||Admitted as a lawyer, England, Wales|
|2000||Graduate Diploma in Law, Nottingham Law School|
|1998||BSc in Cell Biology, Durham University|
Advising gene therapy company AlveoGene on its complex spinout and launch investment
Word on the street at the J.P. Morgan Healthcare Conference 2023